期刊文献+

细胞DNA定量分析技术在宫颈癌筛查中的应用 被引量:4

The application of DNA- image cytometry in cervical cancer screening
下载PDF
导出
摘要 目的:比较和评估两种宫颈癌筛查方法的应用价值。方法:选取2010年1月至2013年2月到漳浦县医院进行宫颈癌检查的病例14119例。均为宫颈刷取材,液基方法同时制两张片,一张进行巴氏染色,用于常规细胞学TBS诊断。另一张经Feulgen染色,用于细胞DNA定量分析检测。临床活检取材均在阴道镜指导下进行。结果:共建议活检671例。用于回顾性研究的388例有活检结果。其中有宫颈癌5例,CINⅢ/原位癌38例,44例CINⅡ及137例CINⅠ,其余164例为慢性宫颈炎。以活检结果≥CINⅡ作为宫颈癌前病变的阳性标准,采用细胞DNA定量分析检测的敏感性分别为70.11%与97.7%,而常规细胞学检测的敏感性分别为45.98%与58.62%。同一个标本同时采用两种方法联合检测,敏感性可提高到99.89%。结论:细胞DNA定量分析技术可作为宫颈癌及癌前病变检测的辅助手段。 Objective: To evaluate the application value of DNA image cytometry ( DNA - ICM ) in the screening of cervical carcinoma. Methods: All 14119 women screened from 2010 to 2013 were reviewed. The cytology samples were taken by cervix brush and prepared to 2 slides for each case : one was Pap - stained and read by cytologist ac- cording to the TBS criteria,the other was Feulgen -stained, scanned and analyzed by DNA -ICM. The biopsies were conducted with the guidance of eolposcopy. Results:In the retrospective study,388 in 671 women recommended were reported with biopsy results which included 5 cases with cervical cancer, 38 CINⅢ/CIS eases,44 CIN Ⅱ and 137 CIN I . The sensitivity of DNA - ICM were 70.11% and 97.7% ,while the TBS report of cervical cytology test were 45.98% and 58.62%. The sensitivity increased to 99.89% when combining the both. Conclusion : DNA - ICM is a useful adjunct for cervical cancer screening combined with cervical cytology test.
作者 陈湧彧
出处 《现代肿瘤医学》 CAS 2015年第8期1116-1118,共3页 Journal of Modern Oncology
关键词 细胞DNA倍体定量分析 宫颈癌 筛查 DNA - ICM cervical cancer screening
  • 相关文献

参考文献14

  • 1Cornelison TL,Montz FJ,Bristow RE,et al.Decreased incidence of cervical cancer in medicare-eligible California women[J].Obstet Gynecol,2002,100:79-86.
  • 2Howlett RI,Marrett LD,Innes MK,et al.Decreasing incidence of cervical adenocarcinoma in Ontario:is this related to improved endocervical Pap test sampling[J]? Int J Cancer,2007,120:362-367.
  • 3魏丽惠.何为宫颈癌筛查的适宜方法[J].中国妇产科临床杂志,2010,11(2):83-84. 被引量:26
  • 4Ganem Neil J,Storchova Zuzana,Pellman David.Tetraploidy,aneuploidy and cancer[J].Current Opinion in Genetics & Development,2007,2:157-162.
  • 5David J Gordon,Benjamin Resio,David Pellman.Causes and consequences of aneuploidy in cancer Nature Reviews[J].Genetics,2012,13:189.
  • 6Anderson G,MacAulay CF,Matisic J,et al.The use of an automated image cytometer for screening and quantitative assessment of cervical lesions for screening.Columbia Cervical Smear Screening Programme[J].Cytopathology,1997,8:298-312.
  • 7Bocking A,Nguyen VQ.Diagnostic and prognostic use of DNA image cytometry in cervical squamous intraepithelial lesions and invasive carcinoma[J].Cancer (Cancer Cytopathology),2004,102:41-54.
  • 8帅采芹.修水县宫颈癌筛查结果分析[J].实用癌症杂志,2010,25(3):319-320. 被引量:7
  • 9Tezcan A,Garner DM,Lam P,et al.Analysis of thionin,gallocyanin,and hematoxylin for automated quantitative image cytometry of cervical samples[J].Clinical Applications of Cytometry,1993,3:15-18.
  • 10M Guillaud,JL Benedet,SB Cantor,et al.DNA ploidy compared with human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation[J].Cancer,2006,107(2):21.

二级参考文献14

  • 1屠铮,李静,赵超,宋丹,崔淑慧,章文华,乔友林,Belinson JL,魏丽惠.醋白肉眼观察试验在宫颈病变筛查中的价值[J].中国妇产科临床杂志,2007,8(2):90-92. 被引量:25
  • 2National Institutes of Health. Cervical cancer. NIH Consen sus Statement, 1996, 14: 1-38.
  • 3Editorial. Women's health in rural China. Lancet, 2009, August 1: 358.
  • 4刘树范.子宫颈病变的细胞病理学∥:连丽娟.林巧稚妇科肿瘤学.4版.北京:人民卫生出版社,2006:288-311.
  • 5Thomas C, Wright Jr, L, Massad S, et al. 2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests. American Society for Colposcopy and Cervical Pathology Journal of Lower Genital Tract Disease, 2007, 11: 201-222.
  • 6Naucler P, Ryd W, Tornberg S, et, al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer lnst, 2009, 101: 88-99.
  • 7Mayrand MH, Eliane DF, Rodrigues I, et al. Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer. N Engl J Med, 2007 18: 357:1579 - 1588.
  • 8Denny L, Kuhn L, De Souza M, et al. Screen - and - treat approaches for cervical cancer prevention in low - resource settings: a randomized controlled trial. JAMA, 2005, 2941 2173 2181.
  • 9Caglel AJ, Hu SY. Sellors JW, et al. Use of an expanded gold standard to estimate the accuracy of oolposcopy and visual inspectionwith acetic acid. Int J Cancer, 2009, 126: 156- 161.
  • 10Cantor SB, Cardenas- Turanzas M, Cox DD, et al. Accuracy of Colposcopy in the Diagnostic Setting Compared With the Screening Setting. Obstet Gynecol, 2008, 111:7- 14.

共引文献30

同被引文献49

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部